Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 1/2 2Phase 3 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Melanoma 106Carcinoma, Non-Small-Cell Lung 34Carcinoma, Renal Cell 23Prostatic Neoplasms 17Neoplasms 15Brain Neoplasms 15Neoplasm Metastasis 14Lung Neoplasms 12Breast Neoplasms 11Uveal Melanoma 10Pancreatic Neoplasms 10Sarcoma 9Small Cell Lung Carcinoma 7Urinary Bladder Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Kidney Neoplasms 6Diabetes Mellitus, Insulin-Dependent, 12 6Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Skin Neoplasms 5Ovarian Neoplasms 5Histiocytoma, Malignant Fibrous 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Recurrence 4Neuroendocrine Tumors 4Mesothelioma 4Glioblastoma 4Colonic Neoplasms 4

Interventions

Nivolumab 8Specimen Handling 4Ipilimumab 4cabozantinib 3Sunitinib 3Radiosurgery 3pembrolizumab 2pazopanib 2Everolimus 2CTLA-4 Antigen 2Biopsy 2Axitinib 2tivozanib 1sodium-iodide symporter 1sitravatinib 1lenvatinib 1Zoledronic Acid 1Radiotherapy 1Pluvicto 1Nephrectomy 1Metastasectomy 1Magnetic Resonance Spectroscopy 1LY2510924 1Interleukin-2 1Ibandronic Acid 1Diphosphonates 1Denosumab 1Cytoreduction Surgical Procedures 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Clear-cell metastatic renal cell carcinoma × Ipilimumab × Clear all
NCT05361720 2026-04-27

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Vanderbilt-Ingram Cancer Center

Phase 2 Recruiting
54 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07510334 2026-04-03

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Mayo Clinic

Phase 2 Not yet recruiting
18 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT02917772 2022-10-06

TITAN-RCC

AIO-Studien-gGmbH

Phase 2 Completed
200 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT02960906 2021-04-26

BIONIKK

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 2 Completed
200 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡